Aleva Neurotherapeutics SA

ALEVA is THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads*

Today we are A SOLID COMPANY that following directSTIM™’s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets.

We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to COMBINE SPECIALISATION with the COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you.

We are the ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor.
Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide.

Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS:
a new group of investors that will sustain the completion of OUR PROJECT
a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision.

*May 28, 2014 http://doi.org/10.1093/brain/awu102.

Company’s Keywords:

neurosurgery, deep brain stimulation, medical device development